A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

Onset under the age of 2 years (not used in children below the age of 4 years). Data taken from reference 54. The incidence of atopic dermatitis has increased two- to threefold in industrialized ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

WEDNESDAY, Dec. 11, 2024 (HealthDay News) — Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), today announced financial results for its ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Unspecified Respiratory Disorders.